Showing posts with label hepatoprotection. Show all posts
Showing posts with label hepatoprotection. Show all posts

Monday, 2 May 2022

Determine the Protective Effect of Acorus calamus Rhizome in Paracetamol Exposure Induced Hepatotoxicity in Rats| Chapter 15 | Challenges and Advances in Pharmaceutical Research Vol. 2

Background: Because the liver is the primary organ for xenobiotic biotransformation, hepatic diseases or degeneration are still a serious health concern today. Even if there are several antioxidants and hepatoprotectives available, liver deterioration that has progressed beyond the ability to heal culminates in liver failure and death.


The goal of this study was to see if an aqueous and alcoholic extract of Acorus calamus rhizomes might protect rats against paracetamol-induced hepatotoxicity.

Hepatotoxicity was caused by taking paracetamol orally, and chemical parameters such glutathione peroxidase, glutathione reductase, glutathione, Catalase, lipid peroxidation, and histological alterations in the liver were compared to Silymarin, a typical hepatoprotective medication.

After paracetamol administration, treatment of rats with aqueous and alcoholic extracts of Acoruscalamus rhizome normalised the changed levels of the aforesaid parameters, which may be equivalent to Silymarin and Vit-E. Histopathological analysis of the liver tissue of control and treated animals verified the hepatoprotective action.

Conclusion: Based on the findings, it may be inferred that the rhizome of Acorus calamus protects rats against paracetamol-induced hepatotoxicity. The usage of Acoruscalamus may be indicated for lifestyle-related disorders such as hepatitis, as well as to promote overall health in animals, including humans. Prior to the therapeutic use of Acoruscalamus as an antioxidant, extensive investigations in target species should be conducted.

 

Author(s) Details:

G. Srividya,
Department of Veterinary Pharmacology and Toxicology, N. T. R College of Veterinary Science, Gannavaram, India.

K. Adilaxmamma,
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science Tirupati, Andhrapradesh, India.

C. H. Srilatha,
Department of Veterinary Pathology, College of Veterinary Science Tirupati, Andhrapradesh, India.

Please see the link here: https://stm.bookpi.org/CAPR-V2/article/view/6587

Saturday, 21 August 2021

Tomato (Lycopersicon esculentum) Extracts Elicit Anti-Hepatotoxic Effects on Acetaminophen-Induced Liver Injury in Albino Wistar Rat | Chapter 4 | Technological Innovation in Pharmaceutical Research Vol. 10

 Introduction: Drug overdose is the largest cause of liver injury in the world today, according to numerous reports. Natural antioxidant-rich diets have been shown to provide significant relief from drug-induced organ damage.

The goal of this investigation was to see if tomato extract could protect rats from acetaminophen-induced acute hepatotoxicity.

Methods: Phytochemical tests were carried out. A total of 24 albino rats weighing 11010 g were divided into four groups (A-D), each with six rats. The usual control group, Group A, received no treatment. The negative control group got only a single dose of acetaminophen (750 mg/kg, i.p) as a single dose. The test group got a single dose of acetaminophen (750 mg/kg, i.p.) before receiving 14 days of therapy with tomato extract (30 mg/kg, oral). For 14 days, Group D was given tomato extract (30 mg/kg, oral) and acetaminophen (750 mg/kg, i.p) at the same time.

When compared to normal (p0.05 or p0.01), a single dosage of Acetaminophen induced liver cell damage and a significant increase in the levels of the liver enzymes: AST (67.6711.41U/L); ALT (46.3310.59U/L); and ALP (223.7023.31U/L) in rats in negative control. On the liver enzyme marker levels, daily injection of tomato extract was able to reduce the acetaminophen-induced hepatotoxicity: AST (23.00 3.61U/L, P0.01), ALT (17.67 3.48U/L, P0.05), and ALP (121.308.11U/L, P0.01) were all higher in Group C. When compared to the negative control group, AST (26.672.91U/L, P0.01), ALT (18.671.76 U/L, P0.05), and ALP (124.729.33U/L, P0.01) were significantly higher in Group D. In comparison to the normal control group, histological data demonstrated no substantial liver injury in the tomato extract groups.

Tomato extract has hepatoprotective properties against acetaminophen-induced liver damage.

Author (S) Details

I. K. Uchendu
Department of Medical Laboratory Science, Division of Clinical Chemistry, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

C. E. Agu
Department of Medical Laboratory Science, Division of Clinical Chemistry, University of Calabar, Nigeria.

O. C. Orji
Department of Medical Laboratory Science, Division of Clinical Chemistry, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

E. B. Nnedu
Department of Medical Laboratory Science, Division of Immunology, University of Nigeria, Enugu Campus, Nigeria.

C. Arinze
Department of Medical Laboratory Science, Division of Clinical Chemistry, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

A. C. Uchenna
Department of Medical Laboratory Science, Division of Medical Microbiology, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

U. C. Okongwu
Department of Medical Laboratory Science, Division of Medical Microbiology, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

View Book :- https://stm.bookpi.org/TIPR-V10/article/view/2841

Study on the effect of Aqueous Extract of Bitter Leaf (Vernonia amygdalina) Against Acetaminophen-Induced Liver Damage in Rats | Chapter 3 | Technological Innovation in Pharmaceutical Research Vol. 10

 The goal of this investigation was to see if Vernonia amygdalina aqueous extract could protect abino wistar rats against acetaminophen-induced liver injury.


Methods: Twenty-five (25) albino rats weighing 120–20 g were allocated into five (5) groups, each with five (5) rats. Group A was used as a control group and did not receive any treatment. As a negative control, Group B received only a single dosage of acetaminophen (750 mg/kg, i.p.). Following an acetaminophen challenge, Group C got Vitamin C (200 mg/kg, oral) for 2 weeks, whereas Group D and E received aqueous bitter leaf extract; high dose (500 mg/kg, oral) and low dose (250 mg/kg, oral) separately for 2 weeks.

Results: A single dose of acetaminophen (750 mg/kg, i.p.) caused liver damage, with AST, ALT, and ALP values of 48.3310.14, 60.0013.23, and 229.6723.38U/L, respectively. When compared to acetaminophen alone, bitter leaf treatment reversed acetaminophen-induced liver damage, with AST, ALT, and ALP levels of 20.671.76U/L (P0.05), 16.673.52U/L (P0.01), and 131.677.27U/L (P0.01), respectively. The test groups likewise had mild or non-significant hepatic damage, indicating that Vernonia amygdalina provides hepatoprotection.

Conclusion: Vernonia amygdalina aqueous extract has hepatoprotective effects against acetaminophen-induced liver injury.

Author (S) Details

I. K. Uchendu
Department of Medical Laboratory Science, Division of Clinical Chemistry, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

View Book :- https://stm.bookpi.org/TIPR-V10/article/view/2840